Live Breaking News & Updates on James Thoracic Center

Stay updated with breaking news from James thoracic center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lung Specialist Finds His "Sweet Spot" at the Intersection of Medicine and Technology

David P. Carbone, MD, PhD, sought to transform lung cancer care and did it but didn’t anticipate the personal journey it would put him on. ....

Johns Hopkins University , United States , University Of Texas Southwestern Medical Center , Vanderbilt University , Dana Farber Cancer Institute , New York , Johns Hopkins Hospital , Ohio State University , National Institutes Of Health , Cancer Institute , Al Qahirah , Haroldl Moses , William Osler , Bonniej Addario , Jasleen Pannu , Heidi Onda , Paul Carbone , Johns Hopkins , Alessandra Ferrajoli , Davidp Johnson , Robert Goldsmith , John Minna , Johns Hopkins Medical School , Life Sciences , Amherst College , Ohio State University Comprehensive Cancer Center ,

Conquering Lung Cancer

Conquering Lung Cancer
wcbe.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcbe.org Daily Mail and Mail on Sunday newspapers.

United States , Ohio State University , Barbaraj Bonner , Davidp Carbone , Cierra Johnson , Jasleen Pannu , Interventional Pulmonary Translational Research , James Thoracic Center , Ohio State University Comprehensive Cancer Center , Translational Therapeutics Program , Division Of Pulmonary , National Smoking Cessation Month , Ohio State University Wexner Medical Center , Lung Cancer Research , Stanford Medicine , Lung Cancer Awareness , Assistant Professor , Critical Care , Sleep Medicine ,

Frontline Nivolumab/Ipilimumab Plus Chemotherapy Maintains Efficacy Advantage in Metastatic NSCLC

Nivolumab plus ipilimumab and chemotherapy continued to show durable benefit at 4 years compared with chemotherapy alone as first-line therapy in patients with advanced non–small cell lung cancer, particularly in the PD-L1–negative and squamous populations. ....

United States , Nivolumab Opdivo , Davidp Carbone , Barbaraj Bonner , European Union , Lung Cancer Research , James Thoracic Center , Ohio State University Comprehensive Cancer Center , Checkmate 9la , Non Small Cell Lung Cancer , Pd L1 , Asco Annual Meeting ,

OncLive Honors 12 Cancer Care Pioneers

For the 11th consecutive year, OncLive is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients. ....

United Kingdom , United States , San Antonio , Puerto Rico , Nikhilc Munshi , Charles Swanton , Ericp Winer , Howardi Scher , Barbaraj Bonner , Fernando Cabanillas , Eduardo Bruera , D Wayne Calloway , Robertc Young , Stephenj Forman , Eileenm Oreilly , Robertf Ozols , Eleftherios Terry Mamounas , Davidp Carbone , Deb Schrag , Susang Komen , Audrey Weg Schaus , Georgej Bosl , Geoffrey Alan Weg , Annh Partridge , Francis Crick Institute , Breast Program ,

Atezolizumab Following Neoadjuvant Atezolizumab and Resection Improves DFS in NSCLC

Data for adjuvant atezolizumab following neoadjuvant atezolizumab and resection demonstrated an improvement in disease-free survival and a trend toward improved overall survival in patients with resectable stage IB to IIIB non–small cell lung cancer compared with those who did not receive adjuvant atezolizumab. ....

United States , Iovance Biotherapeutics , Davidp Carbone , Barbaraj Bonner , Sanofi Genzyme , European Lung Cancer Congress , James Thoracic Center , Lung Cancer Research , James Ohio State Comprehensive Cancer Center , Lung Cancer Congress , Arcus Biosciences , Roche Taiwan , 2023 European Lung Cancer Congress , Neoadjuvant Atezolizumab , Resectable Stage Ib To Iiib Non Small Cell Lung Cancer , Adjuvant Atezolizumab , Phase 2 Lcmc3 Trial Nct02927301 ,